|
Market Closed -
BME
11:35:22 2026-09-25 am EDT
|
5-day change | 1st Jan Change | ||
| 59.15 EUR | -0.59% |
|
+2.60% | -6.85% |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 19.98x | 4.02x | 2.61x | 3.9x | 15.27x | 18.35x | 1.65% | 3.45B | ||
| 33.65x | 21.39x | 0.63x | 12.19x | 24.78x | 26.22x | 0.59% | 1,055B | ||
| 30.17x | - | -1.63x | 6.71x | 18.78x | 21.11x | 1.98% | 654B | ||
| 33.43x | -481.38x | 0.14x | 7.82x | 16.17x | 16.85x | 2.59% | 467B | ||
| 19.59x | 7.16x | 1.34x | 4.78x | 11.84x | 13.13x | 2.78% | 348B | ||
| 20.4x | 5.8x | -11.77x | 5.31x | 13.17x | 14.05x | 3.01% | 275B | ||
| 21.19x | 4.77x | 1.06x | 4.39x | 12.5x | 13.15x | 2.01% | 258B | ||
| 26.19x | 19.81x | 2.32x | 6.82x | 12.15x | 15.66x | 2.43% | 224B | ||
| -45.65x | 11.24x | 0.31x | 6.64x | 25.94x | 62.94x | 2.18% | 187B | ||
| 11.33x | 4.78x | -3.77x | 4.13x | 8.58x | 10.04x | 4.44% | 171B | ||
| 18.08x | 1.86x | 1.09x | 3.39x | 8.68x | 9.87x | 6% | 163B | ||
| 54.08x | 8.54x | -1.48x | 9.74x | 33.41x | 26.89x | -.--% | 133B | ||
| 11.2x | 5.28x | 0.18x | 3.15x | 8.2x | 8.83x | 4.02% | 128B | ||
| 14.36x | 4.58x | -1.66x | 2.81x | 8.32x | 9.25x | 3.76% | 98.2B | ||
| 11.43x | 1.16x | -6.05x | 2.05x | 6.62x | 7.32x | 5.93% | 98.02B | ||
| 21.58x | 4.86x | 1.33x | 7.22x | 13.7x | 14.43x | 2.04% | 69.17B | ||
| 47.26x | 1.28x | 13.41x | 2.86x | 10.47x | 28.58x | 3.42% | 60.57B | ||
| 22.63x | 1.74x | -0.14x | 1.73x | 8.14x | 13.98x | 0.32% | 56B | ||
| 32.22x | 4.35x | 1.79x | 7.51x | 25.44x | 28.46x | 0.54% | 44B | ||
| Average | 21.22x | -20.49x | -0.02x | 5.43x | 14.85x | 18.90x | 2.62% | 236.47B | |
| Weighted average by Cap. | 24.31x | -48.50x | -0.59x | 7.23x | 17.27x | 20.24x | 2.22% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















